Chordate Medical Holding
0.059 SEK -1.68%1 investor is following this company
Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked a nerve-modulating treatment technique for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (KOS). The company sells its products to treating clinics in selected European markets, Israel and Saudi Arabia, with the aim of increasing its presence in the global market.
Revenue
980K
EBIT %
-3,017.35 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CMH
Daily low / high price
0.054 / 0.059
SEK
Market cap
28.6M SEK
Turnover
25.71K SEK
Volume
467K
Financial calendar
General meeting
2024-05-15
Interim report
2024-05-24
Interim report
2024-08-30
Interim report
2024-11-22
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Hawoc Investment AB | 12.1 % | 12.1 % |
Sifonen AB | 9.1 % | 9.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Chordate presents Ozilia to national specialist associations from Germany, Switzerland, & Austria
Chordate presents at the Feminvest investor conference in Oslo
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools